Nearly 20% of patients with type 2 diabetes do not benefit from exercise
the ONA take:
According to a new study published in the Journal of Clinical Endocrinology & Metabolism, one in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control when they participate in a supervised exercise regimen.
For the study, researchers analyzed data from clinical studies that investigated the use of exercise regimens in patients with type 2 diabetes. They also looked at animal and genetic studies that did the same. Results showed that about 15 to 20% of patients with type 2 diabetes did not experience improvement in blood sugar control, insulin sensitivity, or muscle mitochondrial density.
The animal and genetic studies suggest that the resistance to exercise is genetic and can be passed from one generation to the next.
The U.S. Centers for Disease Control and Prevention estimates that about 40% of American will develop type 2 diabetes in their lifetime. Because obesity and lack of exercise are associated with the disease, exercise is often recommended to patients with diabetes to help manage the disease.
This study shows that while most people benefit from exercise, nearly 20% of patients with type 2 diabetes do not as a result of their DNA.
One in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|